HomeBPMC • NASDAQ
add
Blueprint Medicines Corp
Previous close
$96.57
Day range
$89.12 - $95.55
Year range
$80.68 - $121.90
Market cap
5.70B USD
Avg Volume
991.04K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 146.37M | 103.41% |
Operating expense | 180.12M | 1.85% |
Net income | -49.96M | 54.96% |
Net profit margin | -34.13 | 77.86% |
Earnings per share | -0.79 | 56.59% |
EBITDA | -37.20M | 64.08% |
Effective tax rate | -1.36% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 615.49M | -13.39% |
Total assets | 1.18B | 12.44% |
Total liabilities | 881.15M | -4.08% |
Total equity | 298.66M | — |
Shares outstanding | 63.91M | — |
Price to book | 20.59 | — |
Return on assets | -8.66% | — |
Return on capital | -9.96% | — |
Cash Flow
Net change in cash
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -49.96M | 54.96% |
Cash from operations | -29.36M | 62.80% |
Cash from investing | 33.71M | -57.21% |
Cash from financing | 9.76M | -37.15% |
Net change in cash | 12.78M | -19.40% |
Free cash flow | -17.55M | 64.80% |
About
Founded
2008
Website
Employees
649